Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;48(3):366-401.
doi: 10.1111/ceo.13702. Epub 2020 Jan 22.

Local delivery of corticosteroids in clinical ophthalmology: A review

Affiliations
Review

Local delivery of corticosteroids in clinical ophthalmology: A review

Adrian T Fung et al. Clin Exp Ophthalmol. 2020 Apr.

Abstract

Locally administered steroids have a long history in ophthalmology for the treatment of inflammatory conditions. Anterior segment conditions tend to be treated with topical steroids whilst posterior segment conditions generally require periocular, intravitreal or systemic administration for penetration. Over recent decades, the clinical applications of periocular steroid delivery have expanded to a wide range of conditions including macular oedema from retino-vascular conditions. Formulations have been developed with the aim to provide practical, targeted, longer-term and more efficacious therapy whilst minimizing side effects. Herein, we provide a comprehensive overview of the types of periocular steroid delivery, their clinical applications in ophthalmology and their side effects.

Keywords: Fluocinolone acetonide; corticosteroid; dexamethasone; prednisolone acetate; triamcinolone acetonide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Classification of steroids and actions
Figure 2
Figure 2
Common locally administered ophthalmic steroids

Similar articles

Cited by

References

    1. Gordon DM, McLean JM. Effects of pituitary adrenocorticotrophic hormone (ACTH) therapy in ophthalmologic conditions. JAMA. 1950;142:1271‐1276.
    1. Edelman JL. Differentiating intraocular glucocorticoids. Ophthalmologica. 2010;224(Suppl 1):25‐30. 10.1159/000315158. - DOI - PubMed
    1. Whitcup SM, Cidlowski JA, Csaky KG, et al. Pharmacology of corticosteroids for diabetic macular edema. Invest Ophthalmol Vis Sci. 2018;59:1‐12. 10.1167/iovs.17-22259. - DOI - PMC - PubMed
    1. Sulaiman RS, Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in the eye. Steroids. 2018;133:60‐66. 10.1016/j.steroids.2017.11.002. - DOI - PMC - PubMed
    1. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med. 2005;353:1711‐1723. - PubMed